Company Number: OC441869

Analysis Date: 2025-07-20 16:50 UTC

1. Risk Rating: LOW

Justification: Stalex Ventures LLP is a recently incorporated limited liability partnership classified as dormant with no reported assets or liabilities as of the latest accounts. It has complied with filing deadlines and has no overdue reports, indicating regulatory compliance and minimal current operational activity that limits immediate financial risk.

2. Key Concerns:

• Dormant Status: The LLP has been dormant since incorporation, showing no trading activity or financial transactions, which raises questions about operational viability and business sustainability.
• Lack of Financial Substance: Zero net assets and total assets less current liabilities suggest no capital investment or working capital, presenting potential solvency concerns if trading were to commence without new funding.
• Limited Financial Disclosure: The LLP has opted not to file a profit and loss account, restricting visibility into any income or expenses, thus limiting the ability to assess future financial performance or risks.

3. Positive Indicators:

• Regulatory Compliance: The LLP has filed accounts and confirmation statements on time with no overdue filings, suggesting good governance and administration.
• Clear Ownership and Control: The designated members and persons with significant control are identified, providing transparency regarding governance.
• Minimal Obligations: As a dormant entity with no liabilities, immediate solvency or liquidity risks are low.

4. Due Diligence Notes:

• Investigate Intent and Business Plan: Clarify the LLP’s intended purpose, timeline for activation, and planned sources of capital or revenue.
• Review Members’ Financial Capacity: Assess the financial strength of designated members and controlling entities to support future operations or funding requirements.
• Monitor Future Filings: Watch for changes in filing status, financial activity, or disclosures that might indicate commencement of trading and associated risks.